5-Years Data: High-Dose Thoracic Radiotherapy Increases OS Significantly for Patients with Limited Stage of Small-Cell Lung Cancer
Compared with low-dose thoracic radiotherapy, a high dose twice daily can increase overall survival (OS) from 22.6 months to 43.6 months. In this MEDtalk, Bjørn Henning Grønberg, NTNU, Trondheim, Norway, presents interesting data from the study.